Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cefazolin.

R Quintiliani, C H Nightingale

    Annals of Internal Medicine
    |November 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Cefazolin and cephalothin show similar therapeutic effects and adverse reactions after 5 years. Key differences lie in pharmacokinetics and cost-effectiveness, not clinical efficacy or toxicity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Infusion phlebitis: relative incidence associated with cefuroxime administered by intermittent and continuous infusion.

    Clinical drug investigation·2008
    Same author

    A survey of the quality of generic clarithromycin products from 18 countries.

    Clinical drug investigation·2007
    Same author

    In vivo immunomodulatory profile of telithromycin in a murine pneumococcal infection model.

    Die Pharmazie·2006
    Same author

    Intrapulmonary concentrations of telithromycin: clinical implications for respiratory tract infections due to Streptococcus pneumoniae.

    Chemotherapy·2005
    Same author

    Beneficial pharmacokinetic interaction between cyclosporine and itraconazole in renal transplant recipients.

    Transplantation proceedings·2003
    Same author

    Clearance of quinupristin-dalfopristin (Synercid) and their main metabolites during continuous veno-venous hemofiltration (CVVH) with or without dialysis.

    The International journal of artificial organs·2002
    Same journal

    Correction to I.M. Matters News: Sleep medicine for seniors.

    Annals of internal medicine·2026
    Same journal

    Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

    Annals of internal medicine·2026
    Same journal

    Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

    Annals of internal medicine·2026
    Same journal

    Grappling with GLP-1 prescribing.

    Annals of internal medicine·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Microbiology
    • Clinical Therapeutics

    Background:

    • Cefazolin and cephalothin are cephalosporin antibiotics.
    • Understanding their comparative efficacy and safety is crucial for clinical practice.

    Purpose of the Study:

    • To compare the therapeutic effectiveness, adverse reactions, and pharmacokinetic profiles of cefazolin and cephalothin.

    Main Methods:

    • Analysis of clinical trial data comparing cefazolin and cephalothin.
    • Evaluation of in-vitro susceptibility to staphylococcal beta-lactamase.
    • Assessment of microbiologic activity against enterobacteriaceae.

    Main Results:

    • Cefazolin and cephalothin demonstrate comparable therapeutic outcomes and adverse reaction profiles.

    Related Experiment Videos

  • Minor differences in in-vitro susceptibility and microbiologic activity do not translate to significant clinical differences.
  • Pharmacokinetic properties and cost-effectiveness present notable distinctions.

    • Conclusions:

    • Cefazolin is therapeutically similar to cephalothin, with comparable safety profiles.
    • Pharmacokinetic variations and cost-effectiveness are the primary differentiating factors between these antibiotics.